Alaunos Therapeutics
TCRTAlgoritmens signaler
- ›Pris under både MA50 och MA200 (svag trend)
- ›Hög volatilitet (53% årlig)
- ›Ökad handelsvolym (+21%)
- ›-72% från 52v-toppen
- ›Svagt 3m-momentum (-42.9%)
📰 Senaste nyheter & analys
Källor: Placera, Nyhetsbyrån Direkt, Google NewsAlaunos Therapeutics (TCRT) Slips 1.89% to $1.56 as Small-Cap Biotech Holds Above Key Support - McClellan Oscillator - siam.in
2026-09-09Alaunos Therapeutics (TCRT) Slips 1.89% to $1.56 as Small-Cap Biotech Holds Above Key Support - McClellan Oscillator siam.in
siam.inAlaunos (TCRT) Latest: Moves 1.13% Lower to $1.76 on the Day; Price Setup: the Supplied Trading Band Runs From $1.67 to $1.85 on the Day - Call Resistance - Vinanet
2026-08-23Alaunos (TCRT) Latest: Moves 1.13% Lower to $1.76 on the Day; Price Setup: the Supplied Trading Band Runs From $1.67 to $1.85 on the Day - Call Resistance Vinanet
VinanetAlaunos (TCRT) Results Versus Estimates: Profit Per Share Falls Below Its Benchmark in the Available Record; Market Move: The Stock Closes Near Unchanged in the Latest Session - Earnings Surprise Report - dars.gov.et
2026-08-20Alaunos (TCRT) Results Versus Estimates: Profit Per Share Falls Below Its Benchmark in the Available Record; Market Move: The Stock Closes Near Unchanged in the Latest Session - Earnings Surprise Report dars.gov.et
dars.gov.etAlaunos Therapeutics (TCRT) Edges Higher as Stock Holds Above Key Support - Jelly Roll Trade - Vinanet
2026-07-23Alaunos Therapeutics (TCRT) Edges Higher as Stock Holds Above Key Support - Jelly Roll Trade Vinanet
VinanetAlaunos Therapeutics Reports Encouraging Early Obesity Drug Results - Stocktwits
2026-05-26Alaunos Therapeutics Reports Encouraging Early Obesity Drug Results Stocktwits
StocktwitsValion Bio Appoints Melinda Lackey as General Counsel
2026-05-04Valion Bio Appoints Melinda Lackey as General Counsel PR Newswire SAN ANTONIO, May 4, 2026 Seasoned Biopharmaceutical Attorney with Deep IP, Clinical-Stage, and Nasdaq Public Company Experience Joi
Tivic Health SystemsPR NewswireAlaunos Therapeutics Inc. (TCRT) reports earnings - qz.com
2025-03-31Alaunos Therapeutics Inc. (TCRT) reports earnings qz.com
qz.comTCRT Stock Price and Chart — NASDAQ:TCRT - TradingView
2022-02-03TCRT Stock Price and Chart — NASDAQ:TCRT TradingView
TradingViewWaterMill Asset Management Issues Statement Regarding Consent Solicitation at Ziopharm Oncology
2020-12-17WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”), a sizable and long-term shareholder of Ziopharm Oncology, Inc. (NASDAQ: ZIOP) (“Ziopharm” or the “Company”), today
ZIOPHARM Oncology IncBusiness WireWaterMill Asset Management Addresses Ziopharm Oncology’s Latest Distortion and Recent Threat
2020-12-12WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”) today responded to the latest element of the low-road campaign that Ziopharm Oncology, Inc. (NASDAQ: ZIOP) (“Ziopha
ZIOPHARM Oncology IncBusiness WireWaterMill Asset Management Reinforces the Need for Meaningful and Urgent Change at Ziopharm Oncology
2020-12-08WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”), which collectively with the other participants in its consent solicitation beneficially owns approximately 3.3% of
ZIOPHARM Oncology IncBusiness WireGlass Lewis Recommends Ziopharm Shareholders Vote on the WHITE Consent Card for All of WaterMill’s Director Candidates and Proposals
2020-12-03WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”) today announced that Glass, Lewis & Co., LLC (“Glass Lewis”), a leading proxy advisory firm, has endorsed its case
ZIOPHARM Oncology IncBusiness WireWaterMill Asset Management Refutes Ziopharm Oncology’s Desperate, Low-Road Smear Campaign
2020-11-28WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”), which collectively with the other participants in its consent solicitation beneficially owns approximately 3.3% of
ZIOPHARM Oncology IncBusiness WireISS Recommends Ziopharm Shareholders Vote for Change on WaterMill Asset Management’s WHITE Consent Card
2020-11-26WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”), which collectively with the other participants in its consent solicitation beneficially owns approximately 3.3% of
ZIOPHARM Oncology IncBusiness WireWaterMill Asset Management Sets the Record Straight Following Ziopharm’s Apparent Attempt to Mislead Shareholders and Rewrite History
2020-11-24WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”), which collectively with the other participants in its consent solicitation beneficially owns approximately 3.3% of
ZIOPHARM Oncology IncBusiness WireWaterMill Asset Management Releases Presentation Detailing the Case for Urgent Change Atop Ziopharm Oncology
2020-11-19WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”), which collectively with the other participants in its consent solicitation beneficially owns approximately 3.3% of
ZIOPHARM Oncology IncBusiness Wire
Klicket på "Köp i Nordnet" öppnar din Nordnet-app om installerad — där loggar du in med BankID. Annars öppnas Nordnets webbsajt där du kan logga in med BankID på samma sätt.